Giampaolo Murri

Giampaolo Murri is a seasoned professional with a robust background in multinational pharmaceutical companies such as Novartis, MSD, Lundbeck, Pfizer, and Abbott.

His expertise lies in market access, payers' mindset, pharmaceutical management, and strategic know-how on pharmaspending regulations and governance.

With a proven track record of successfully leading more than 60 market access projects, Giampaolo has navigated challenges across various therapeutic areas including Oncology, Immunology, HCV, HIV, Rare Diseases, CV & Diabetes, Pain & Inflammation.

He has a multidisciplinary approach to the biotech market, managing in-patent and off-patent products, generics, and biosimilars.

Giampaolo's strong team management skills have been evidenced in leading teams of varying sizes, focusing on leadership, engagement, goal-sharing, and problem-solving.

Additionally, he has shared his expertise as a faculty member in Courses/Masters in Market Access and healthcare organizations management.

Giampaolo's educational background includes studies in Economics/Management at LUISS Guido Carli University and completion of the Pfizer European Leadership Development Program at INSEAD.

Throughout his career, he has held key roles such as Market Access Director at Novartis Oncology Italy, Market Access & Commercial Operations Executive Director at Merck, and various leadership positions at Pfizer and Abbott.

With a deep understanding of pricing, reimbursement, outcomes research, and product management, Giampaolo Murri is a respected figure in the pharmaceutical industry.